Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)
Sponsors
Spero Therapeutics
Conditions
Healthy VolunteersRenal ImpairmentTQT Study
Phase 1
Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function
CompletedNCT04178577
Start: 2019-12-06End: 2020-09-11Updated: 2020-11-27
A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects
CompletedNCT04238195
Start: 2020-01-19End: 2020-02-26Updated: 2020-03-13
Study to Examine the Effect of Antacid and Omeprazole on the Single-Dose Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects
CompletedNCT04368585
Start: 2020-07-01End: 2020-08-21Updated: 2020-09-04